![Thane Wettig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 204 190 $ al 30/06/2026
Thane Wettig is Chief Executive Officer & Director at Kyntra Bio, Inc. since 2023.
Former roles include Chief Commercial Officer at Intarcia Therapeutics, Inc. and Vice President-Diabetes Brands Global Marketing at Lilly Diabetes from 2004 to 2009.
Education includes undergraduate and MBA degrees from Washington University in St. Louis.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
KYNTRA BIO, INC. 0,67 % | 06/06/2026 | 27.045 ( 0,67 % ) | 204 190 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KYNTRA BIO, INC. | Director Ejecutivo | 23/07/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
Lilly Diabetes | Corporate Officer/Principal | 01/01/2009 |
Intarcia Therapeutics, Inc.
 Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops innovative therapies utilizing the Medici drug delivery system | Health Technology |
Lilly Diabetes |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
